Geovax Labs (GOVX)

Clinical Trial Expansion Continues With A Stream Of Milestones


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
October 31, 2023
Report ID: 26198
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Geovax Labs
Geovax Labs
Healthcare
Biotechnology
Ticker
GOVX
Current Price
$2.3 -2.54%
Market Cap
$4.1M
Price Target
Refer to Report
Volume
6.5K
52wk Range
$2.16 - $12.9
Related Research Reports
2/7/2024

Initial Phase 2 Data Shows Immune Responses In COVID-19 Booster Trial
Initial Phase 2 Data Shows Immune Responses In COVID-19 Booster Trial (GOVX)
11/9/2023

3Q23 Quarterly Report Includes 2024 Milestones
3Q23 Quarterly Report Includes 2024 Milestones (GOVX)
10/31/2023

Clinical Trial Expansion Continues With A Stream Of Milestones
Clinical Trial Expansion Continues With A Stream Of Milestones (GOVX)
9/25/2023

Positive Data From CM04S1 Phase 2 and Preclinical Trials
Positive Data From CM04S1 Phase 2 and Preclinical Trials (GOVX)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.